PMCRBDSPS: A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery

Sponsor
Peking University People's Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03009747
Collaborator
The First People's Hospital of Changzhou (Other), Peking University Cancer Hospital & Institute (Other), Beijing Friendship Hospital (Other), Guangdong Provincial Hospital of Traditional Chinese Medicine (Other), Hebei Medical University Fourth Hospital (Other), the first affiliated hospital of Jiamusi university (Other), China-Japan Friendship Hospital (Other), The First Hospital of Jilin University (Other), The First Affiliated Hospital of Anhui Medical University (Other), The Affiliated Hospital of the Chinese Academy of Military Medical Sciences (Other), Xiangya Hospital of Central South University (Other), Qilu Hospital of Shandong University (Qingdao) (Other), Peking University International Hospital (Other)
460
35

Study Details

Study Description

Brief Summary

This research plans to collect rectal cancer patients after sphincter-preserving surgery from 14 institutions in China mainland, observe the incidence and risk factors about bowel dysfunction after operation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    460 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Prospective, Randomization and Clinic Cohort Observational Study From Multi Institutions on Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
    Study Start Date :
    Jan 1, 2017
    Anticipated Primary Completion Date :
    Dec 1, 2018
    Anticipated Study Completion Date :
    Dec 1, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    sphincter-preserving surgery

    Patients meet the inclusion criteria will be enrolled into this observing group

    Outcome Measures

    Primary Outcome Measures

    1. Incidence of bowel dysfunction after sphincter-preserving surgery [one year]

    2. Risk factors of bowel dysfunction after sphincter-preserving surgery [one year]

    Secondary Outcome Measures

    1. Incidence of each symptoms of bowel dysfunction [one year]

    2. Prognosis of bowel dysfunction after sphincter-preserving surgery [one year]

    3. Incidence of bowel dysfunction after sphincter-preserving surgery [one year]

      comparing incidences between high and low anastomsis site

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Age ≥ 18 years

    2. Adenocarcinoma confirmed by pathology

    3. Distance from the lowest margin of tumor to the anal verge is ≤ 12cm, confirmed by hard sigmoidoscope.

    4. The tumor is estimated to be resectable and confirmed by multidisciplinary team (MDT).

    5. The operation is estimated to be sphincter-preserving.

    6. The Eastern Cooperative Oncology Group(ECOG) performance status score of patient is ≤

    7. The estimated life time is not less than one year.

    8. The patient agree to sign the informed consent.

    Exclusion Criteria:
    1. The patient refuse to follow research plan.

    2. Emergency case

    3. Pregnant and lactating female patient

    4. The patient did not accept radical resection.

    5. The patient did not accept first stage resection and anastomosis.

    6. The patient has experienced anal-rectal surgery.

    7. The patient has experienced left colon surgery.

    8. The patient suffered long-existing bowel dysfunction before rectal cancer diagnosis.

    9. The patient was diagnosed with cognitive or communicative obstacles.

    10. The patient was diagnosed with serious repeated infection or other concomitance diseases.

    11. The patient has participated other medical research which may affect his/her bowel function.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Peking University People's Hospital
    • The First People's Hospital of Changzhou
    • Peking University Cancer Hospital & Institute
    • Beijing Friendship Hospital
    • Guangdong Provincial Hospital of Traditional Chinese Medicine
    • Hebei Medical University Fourth Hospital
    • the first affiliated hospital of Jiamusi university
    • China-Japan Friendship Hospital
    • The First Hospital of Jilin University
    • The First Affiliated Hospital of Anhui Medical University
    • The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
    • Xiangya Hospital of Central South University
    • Qilu Hospital of Shandong University (Qingdao)
    • Peking University International Hospital

    Investigators

    • Study Chair: Yingjiang Ye, M.D./ PhD, Chinese Society of Colon and Rectal Surgeons

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peking University People's Hospital
    ClinicalTrials.gov Identifier:
    NCT03009747
    Other Study ID Numbers:
    • BaS-1611
    First Posted:
    Jan 4, 2017
    Last Update Posted:
    Jan 4, 2017
    Last Verified:
    Jan 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Peking University People's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 4, 2017